FGF3, fibroblast growth factor 3, 2248

N. diseases: 200; N. variants: 14
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 GeneticVariation disease BEFREE First hints for a correlation between amplification of the Int-2 gene and infection with human papillomavirus in head and neck squamous cell carcinomas. 11016685 2000
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 GeneticVariation disease BEFREE In order to control the data obtained by comparative genomic hybridization (CGH) on DNA sequence copy number amplifications, 20 oral squamous cell carcinomas (SCC) were subjected to interphase fluorescence in situ hybridization (I-FISH) examination using specific DNA probes for the oncogenes int2 and erbB-2, and the corresponding centromeric probes of chromosomes 11 and 17. 9858651 1998
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 AlteredExpression disease BEFREE Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. 8784015 1996
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 Biomarker disease BEFREE Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. 7539284 1995
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 GeneticVariation disease BEFREE Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1. 7685625 1993
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 AlteredExpression disease BEFREE Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. 1997190 1991
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 Biomarker disease BEFREE These studies indicate that gene amplification, especially of INT2, is a prominent abnormality in head and neck squamous cell cancer. 1777414 1991
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 Biomarker disease BEFREE The results indicate that int-2 is frequently amplified in SCC of the head and neck and suggest that int-2 amplification may correlate with clinical disease progression. 2193294 1990
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.090 Biomarker disease BEFREE Amplification of human int-2 in breast cancers and squamous carcinomas. 2895446 1988